[New experiences in the toxicologically controlled therapy of an unusually serious poisoning with nitrostigmine (E605 forte)].
D000110:Acetylcholinesterase / Q000097:blood; D000138:Acidosis / Q000209:etiology; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001285:Atropine / Q000008:administration & dosage*; D001639:Bicarbonates / Q000097:blood; D002849:Chromatography, Gas; D004912:Erythrocytes / Q000032:analysis; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D005750:Gastric Juice / Q000032:analysis; D006801:Humans; D008875:Middle Aged; D010278:Parathion / Q000032:analysis / Q000097:blood / Q000506:poisoning*; D011041:Poisoning / Q000150:complications / Q000201:enzymology / Q000628:therapy; D011188:Potassium / Q000097:blood; D012964:Sodium / Q000097:blood
D001639:Bicarbonates; D010278:Parathion; D001285:Atropine; D012964:Sodium; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000110:Acetylcholinesterase; D011188:Potassium
Neue Erfahrungen bei der toxikologisch kontrollierten Therapie einer ungewöhnlich schweren Vergiftung mit Nitrostigmin (E 605 forte)